BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1083700)

  • 1. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-antitrypsin and its deficiency.
    Kueppers F; Black LF
    Am Rev Respir Dis; 1974 Aug; 110(2):176-94. PubMed ID: 4212922
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha 1-antitrypsin deficiency and chronic aspecific respiratory pathology (evaluation of the risk in the heterozygote state)].
    Marsico SA; Cantatore D; Gennarelli E
    Arch Monaldi; 1981; 36(3):119-30. PubMed ID: 6756332
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
    Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B; Hochstrasser K; Marcic I; Ulmer WT
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of alpha1-antitrypsin to inflammatory periodontal disease.
    Peterson RJ; Marsh CL
    J Periodontol; 1979 Jan; 50(1):31-5. PubMed ID: 310876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteases and protease inhibitors; etiologic role in chronic obstructive emphysema].
    Kueppers F
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():700-2. PubMed ID: 6359127
    [No Abstract]   [Full Text] [Related]  

  • 14. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ).
    Cooper DM; Hoeppner V; Cox D; Zamel N; Bryan AC; Levison H
    Am Rev Respir Dis; 1974 Dec; 110(6):708-15. PubMed ID: 4547935
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha 1-antitrypsin deficiency and the flaccid lung syndrome. The heterozygote controversy.
    Klasen EC; Biemond I; Laros CD
    Clin Genet; 1986 Mar; 29(3):211-5. PubMed ID: 3486059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
    Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
    Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteases and protease inhibitors in chronic obstructive lung disease.
    Erikson S
    Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children.
    Vance JC; Hall WJ; Schwartz RH; Hyde RW; Roghmann KJ; Mudholkar GC
    Pediatrics; 1977 Sep; 60(3):263-72. PubMed ID: 302433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1 antitrypsin deficiency].
    Künzer W
    Klin Padiatr; 1977 May; 189(3):199-205. PubMed ID: 327145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.